- Home
- WKEY vs BIAF Comparison
WKEY vs BIAF Comparison
Compare WKEY & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKEY
- BIAF
- Stock Information
- Founded
- WKEY 1999
- BIAF 2014
- Country
- WKEY Switzerland
- BIAF United States
- Employees
- WKEY N/A
- BIAF N/A
- Industry
- WKEY EDP Services
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- WKEY Technology
- BIAF Health Care
- Exchange
- WKEY Nasdaq
- BIAF Nasdaq
- Market Cap
- WKEY 74.5M
- BIAF 12.2M
- IPO Year
- WKEY N/A
- BIAF 2022
- Fundamental
- Price
- WKEY $5.82
- BIAF $0.29
- Analyst Decision
- WKEY Strong Buy
- BIAF Hold
- Analyst Count
- WKEY 1
- BIAF 1
- Target Price
- WKEY $4.00
- BIAF N/A
- AVG Volume (30 Days)
- WKEY 210.8K
- BIAF 12.3M
- Earning Date
- WKEY 07-22-2025
- BIAF 08-13-2025
- Dividend Yield
- WKEY N/A
- BIAF N/A
- EPS Growth
- WKEY N/A
- BIAF N/A
- EPS
- WKEY N/A
- BIAF N/A
- Revenue
- WKEY $11,875,000.00
- BIAF $8,809,228.00
- Revenue This Year
- WKEY $18.18
- BIAF N/A
- Revenue Next Year
- WKEY $112.51
- BIAF $20.00
- P/E Ratio
- WKEY N/A
- BIAF N/A
- Revenue Growth
- WKEY N/A
- BIAF 78.40
- 52 Week Low
- WKEY $1.61
- BIAF $0.16
- 52 Week High
- WKEY $14.00
- BIAF $2.99
- Technical
- Relative Strength Index (RSI)
- WKEY 43.41
- BIAF 49.68
- Support Level
- WKEY $5.72
- BIAF $0.26
- Resistance Level
- WKEY $6.35
- BIAF $0.35
- Average True Range (ATR)
- WKEY 0.41
- BIAF 0.06
- MACD
- WKEY -0.12
- BIAF 0.00
- Stochastic Oscillator
- WKEY 7.14
- BIAF 25.07
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.